Prognostic value of plasma endotoxin levels in patients with cirrhosis

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 9, 1997, Pages 942-945

  Chan, C C ^a   Hwang, S J ^a   Lee, F Y ^a   Wang, S S ^a   Chang, F Y ^a   Li, C P ^a   Chu, C J ^a   Lu, R H ^a   Lee, S D ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Child Pugh classification; Cirrhosis; Endotoxin

Indexed keywords

BILIRUBIN; ENDOTOXIN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOTOXEMIA; FEMALE; HUMAN; LIMULUS LYSATE TEST; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0030808419     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709011206     Document Type: Article

References (37)

1. 51Cr-labeled lipopolysaccharide in tissue culture cells and livers of normal mice. Infect Immun 1976;14:100-5.
2. Ruiter DJ, van der Meulen J, Brouwer A, Hummel MJ, Mauw BJ, van der Ploeg JCM. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 1981;45:38-45.
3. Levin J, Poore TE, Young NS, Margolis S, Zauker NP, Townes AS, et al. Gram-negative sepsis: detection of endotoxemia with the Limulus test: with studies of associated changes in blood coagulation, serum lipids and complement. Ann Intern Med 1972;76:1-7.
4. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-7.
5. Ghosh S, Latimer RD, Gray BM, Harwood RJ, Oduro A. Endotoxin-induced organ injury. Crit Care Med 1993;21:S19-24.
6. Manthous CA, Hall JB, Samsel RW. Endotoxin in human disease part 1: biochemistry, assay, and possible role in diverse disease states. Chest 1993;104:1572-81.
7. Nolan JP. The role of endotoxin in liver injury. Gastroenterology 1975;69:1346-56.
8. Tarao K, So K, Moroi T, Ikeuchi T, Suyama T, Endo O, et al. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance. Gastroenterology 1977; 73:539-42.
9. Elin RJ, Robinson RA, Levine AS, Wolff SM. Lack of clinical usefulness of the Limulus test in the diagnosis of endotoxemia. N Engl J Med 1975;293:521-4.
10. Sturk A, ten Cate JW. Endotoxin testing revisited. Eur J Clin Microbiol 1985;4:382-5.
11. Munford RS. Endotoxin(s) and the liver. Gastroenterology 1978; 75:532-5.
12. Iwanaga S, Monta T, Harada T, Nakamura S, Niwa M, Takada K, et al. Chromogenic substrates for horseshoe crab clotting enzyme - its application for the assay of bacterial endotoxin. Haemostasis 1978;7:183-8.
13. Harris RI, Stone PCW, Stuart J. An improved chromogenic substrate endotoxin assay for clinical use. J Clin Pathol 1983;36: 1145-9.
14. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995;22:165-72.
15. Di Lelio A, Cestari C, Lomazzi A, Beretta L. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 1989;172:389-92.
16. Pugh RNH, Murray-lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
17. Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984;4:430-5.
18. Christensen E, Schlichting P, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N. Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance. Hepatology 1985;5:843-53.
19. Milani A, Marra L, Siciliano M, Rossi L. Prognostic significance of clinical and laboratory parameters in liver cirrhosis. A multi-variate statistical approach. Hepatogastroenterology 1985;32: 270-2.
20. Villeneuve JP, Infante-Rivard C, Ampelas M, Pomier-Layrargues G, Huet PM, Marleau D. Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology 1986;6: 928-31.
21. Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989;24:269-76.
22. 14C] phenacetin breath test to measure hepatic function in man. Hepatology 1984;4:47-52.
23. Renner E, Wietholtz H, Huguenin P, Arnaud MJ, Preisig R. Caffeine: a model compound for measuring liver function. Hepatology 1984;4:38-46.
24. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7: 660-4.
25. Barbare JC, Poupon RE, Jaillon P, Prod'homme S, Darnis F, Poupon RY. Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis. J Hepatol 1985;1:253-59.
26. Poynard T, Zourabichvili O, Hilpert G, Naveau S, Poitrine A, Benatar C, et al. Prognostic value of total serum bilirubin/γ-glutamyl transpeptidase ratio in cirrhotic patients. Hepatology 1984;4:324-7.
27. Bigatello LM, Broitman SA, Fattori L, Di Paoli M, Pontello M, Bevilacqua G, et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol 1987;82:11-5.
28. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984;4:53-8.
29. Kuratsune H, Koda T, Kurahori T. The relationship between endotoxin and the phagocytic activity of the reticuloendothelial system. Hepatogastroenterology 1983;30:79-82.
30. Munford RS, Hall CL. Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice. Infect Immun 1985;48:464-73.
31. Fukuda I, Tanamoto K, Kanegasaki S, Yajima Y, Goto Y. Deacylation of bacterial lipopolysaccharide in rat hepatocytes in vitro. Br J Exp Pathol 1989;70:267-74.
32. Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic a assay. J Hepatol 1991;12:162-9.
33. Ravin HA, Rowley D, Jenkins C, Fine J. On the absorption of bacterial endotoxin from the gastrointestinal tract of the normal and shocked animal. J Exp Med 1960;112:783-92.
34. Garcia-Tsao G, Albillos A, Barden GE, West AB. Bacterial translocation in acute and chronic portal hypertension. Hepatology 1993;17:1081-5.
35. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995;108:1835-41.
36. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994;21:792-6.
37. Bircher J. Assessment of prognosis in advanced liver disease: to score or to measure, that's the question. Hepatology 1986;6: 1036-7.